The CDC collaborates with diagnostics industry leaders to develop a rapid, point-of-need test for avian influenza A/H5 in ...
In our Tool of the Year Awards, we’re recognizing hobbyist tools ranging from wood-carving knives with blades that stay ...
Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good morning, and welcome to the Lucid Diagnostics Third Quarter ...
An AI-based diagnostic system reveals cancerous tissue that may not otherwise be visible during brain tumor surgery. This enables neurosurgeons to remove it while the patient is still under anesthesia ...
A new long COVID study could be a “game changer,” according to local researchers who found that an AI tool can identify ...
This fall, the CDC launched a new program to help reduce diagnostic errors, a leading cause of death in the U.S. Learn how to ...
The AI diagnostic tool developed at Mass General Brigham indicates that long COVID affects about 23% of people, higher than ...
The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...
Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis and liver diseases contribute to its high incidence ...
New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.
Researchers have developed a potential diagnostic tool for schizophrenia by observing how patients process conflicting information.
COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.